Instrument Inactif

Communiqués Cephalon, Inc.

Actions

US1567081096

Papeterie

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

04/05/11	CEPHALON : bond des bénéfices au premier trimestre
30/03/11	CEPHALON : Valeant Pharmaceuticals lance une OPA de 5,7 MdUSD sur CEPHALON

Communiqués

14/10/11	CEPHALON : Teva Completes Acquisition of Cephalon	BU
13/10/11	CEPHALON : Announces Enrollment In the Risk Evaluation and Mitigation Strategy Program for FENTORA and ACTIQ	PU
13/10/11	CEPHALON : Teva and Cephalon Receive European Commission Approval For Acquisition	BU
22/08/11	CEPHALON : Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015	PR
02/08/11	CEPHALON : Reported Financial Results for the Second Quarter of 2011	PR
21/07/11	CEPHALON : Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ	PR
14/07/11	CEPHALON : Shareholders Approve Acquisition by Teva	PU
29/06/11	CEPHALON : to Release Second Quarter 2011 Earnings Results After the Market Close on August 2, 2011	PR
25/06/11	CEPHALON : Faruqi & Faruqi, LLP Announces Investigation of Cephalon, Inc.	BU
20/05/11	CEPHALON : Granted Temporary Restraining Order in AMRIX® Patent Litigation	PU
20/05/11	CEPHALON : Granted Temporary Restraining Order in AMRIX® Patent Litigation	PR
19/05/11	CEPHALON : Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Cephalon, Inc.	BU
11/05/11	CEPHALON : Recognizes National Night Shift Worker's Day, Honors America's Shift Workers	PR
10/05/11	CEPHALON : The Law Firm of Weiss & Lurie Investigates the Acquisition of Cephalon, Inc.	BU
04/05/11	CEPHALON : The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Cephalon, Inc. in Connection with the Sale of the Company to Teva Pharmaceutical Industries Ltd. -- CEPH	BU
04/05/11	CEPHALON : Brower Piven Announces an Investigation of the Acquisition of Cephalon, Inc. by Teva Pharmaceutical Industries Ltd.	BU
03/05/11	CEPHALON : Reported Strong Financial Results for the First Quarter of 2011	PR
03/05/11	CEPHALON : Briscoe Law Firm Investigates Cephalon, Inc. for Shareholders Concerning Acquisition by Teva Pharmaceutical Industries Ltd.	BU
03/05/11	CEPHALON : Goldfarb Branham Law Firm LLP Investigating Shareholder Claims in Cephalon, Inc. Buyout	BU
03/05/11	CEPHALON : The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Cephalon, Inc. in Connection with the Sale of the Company to Teva Pharmaceutical Industries Ltd. -- CEPH	BU
02/05/11	CEPHALON : Robbins Umeda LLP Is Investigating Cephalon, Inc. Acquisition for Shareholders	BU
02/05/11	CEPHALON : The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Cephalon, Inc. in Connection with the Sale of the Company to Teva Pharmaceutical Industries Ltd. -- CEPH	BU
02/05/11	CEPHALON : to Release First Quarter 2011 Earnings Results After the Market Close on May 3, 2011	PR
02/05/11	CEPHALON : Teva to Acquire Cephalon in $6.8 Billion Transaction	BU
21/04/11	CEPHALON : Valeant Pharmaceuticals Responds to Cephalon Board's Letter	PR